Verrica Pharmaceuticals Inc
(NAS:VRCA)
$
7.45
0.24 (3.33%)
Market Cap: 316.03 Mil
Enterprise Value: 313.53 Mil
PE Ratio: 0
PB Ratio: 206.94
GF Score: 41/100 Verrica Pharmaceuticals Inc (VRCA) Transcripts
- Q1 2024 Verrica Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2024$9.56 (+19.50%)Earnings
- Q4 2023 Verrica Pharmaceuticals Inc Earnings Call TranscriptFeb 29, 2024$5.27 (-7.87%)Earnings
- Q3 2023 Verrica Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023$3.21 (-9.83%)Earnings
- Verrica Pharmaceuticals Inc to Host KOL Event (Virtual) TranscriptOct 11, 2023
- Verrica Pharmaceuticals Inc to Discuss FDA Approval of YCANTH Call TranscriptJul 24, 2023
- Verrica Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Verrica Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Verrica Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Verrica Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Verrica Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 14, 2022
- Verrica Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Verrica Pharmaceuticals Inc VIRTUAL PANEL: The Pursuit of Molluscum - Beetlejuice and Nobel Prizes TranscriptSep 22, 2020
- 1